Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 11:53 am Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Eventide Asset Management, LLC | 138,821 0.600% |
-1,541,179![]() (-91.74%) |
Filing History |
2022-02-14 08:57 am Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 1,500,000 6.130% |
233,116![]() (+18.40%) |
Filing History |
2022-02-11 5:28 pm Unchanged |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Vivo Ventures VI LLC | 1,383,179 5.700% |
0 (Unchanged) |
Filing History |
2022-02-11 5:03 pm Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 7.100% |
449,848![]() (+34.70%) |
Filing History |
2022-02-11 4:09 pm Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Flynn James E | 1,175,131 4.800% |
-630,906![]() (-34.93%) |
Filing History |
2022-02-10 5:11 pm Sale |
2021-02-09 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Longwood Fund II L.P. | 7,801 0.030% |
-926,683![]() (-99.17%) |
Filing History |
2022-02-04 2:31 pm Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FRANKLIN RESOURCES INC BEN |
1,252,142 5.100% |
1,252,142![]() (New Position) |
Filing History |
2022-02-04 09:27 am Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Wellington Management Group LLP | 1,811,505 7.400% |
1,811,505![]() (New Position) |
Filing History |
2022-01-31 5:49 pm Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
BlackRock Inc. BLK |
1,504,620 6.100% |
391,240![]() (+35.14%) |
Filing History |
2022-01-31 5:00 pm Purchase |
2022-01-26 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 1,572,192 6.400% |
303,463![]() (+23.92%) |
Filing History |
2021-12-30 4:33 pm Purchase |
2021-12-21 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 1,268,729 5.200% |
1,268,729![]() (New Position) |
Filing History |
2021-10-25 5:16 pm Purchase |
2021-10-21 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 1,266,884 5.180% |
1,266,884![]() (New Position) |
Filing History |
2021-09-17 4:54 pm Purchase |
2021-09-07 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,296,452 5.300% |
1,296,452![]() (New Position) |
Filing History |
2021-06-10 11:37 am Sale |
2021-06-09 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FMR LLC | 1,011,500 4.141% |
-628,778![]() (-38.33%) |
Filing History |
2021-05-27 4:44 pm Purchase |
2021-05-24 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 1,399,489 5.700% |
613,219![]() (+77.99%) |
Filing History |
2021-05-07 4:56 pm Purchase |
2021-04-27 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Flynn James E | 1,806,037 7.430% |
1,806,037![]() (New Position) |
Filing History |
2021-02-16 4:03 pm Sale |
2021-02-09 | 13D | KalVista Pharmaceuticals, Inc. KALV |
SVLSF IV LLC | 0 0.000% |
-1,769,576![]() (Position Closed) |
Filing History |
2021-02-16 08:31 am Purchase |
2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Ikarian Capital LLC | 1,063,961 5.900% |
117,356![]() (+12.40%) |
Filing History |
2021-02-12 4:30 pm Purchase |
2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Vivo Ventures VI LLC | 1,383,179 5.900% |
360,686![]() (+35.28%) |
Filing History |
2021-02-08 10:25 am Sale |
2021-02-05 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FMR LLC | 1,640,278 9.142% |
-150,513![]() (-8.40%) |
Filing History |